Clinical Trials Browser

Interventional × Endometrial Adenocarcinoma × Medroxyprogesterone × Clear all

NCT00064025 2016-04-11

Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus

Phase 2 Completed

75 enrolled 6 charts

Endometrial Adenocarcinoma